1-8 of 8
Richard Pazdur
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PD4-08: An FDA analysis of survival outcomes comparing adjuvant paclitaxel and trastuzumab trial (APT) to an external control from historical clinical trials

Laleh Amiri-Kordestani, Diqiong Xie, Erik Bloomquist, Shenghui Tang, Richard Pazdur, Rajeshwari Sridhara, Sara M Tolaney, Eric P Winer, Julia A Beaver
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): PD4-08.
https://doi.org/10.1158/1538-7445.SABCS19-PD4-08
Published: 15 February 2020
View article titled, Abstract PD4-08: An FDA analysis of survival outcomes comparing adjuvant paclitaxel and trastuzumab trial (APT) to an external control from historical clinical trials
Journal Articles

Abstract PD2-07: Prediction of CDK inhibitor efficacy in ER+/HER2- breast cancer using machine learning algorithms

Jeremy Mason, Yutao Gong, Laleh Amiri-Kordestani, Suparna Wedam, Jennifer J Gao, Harpreet Singh, Richard Pazdur, Peter Kuhn, Gideon Blumenthal, Julia A Beaver
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): PD2-07.
https://doi.org/10.1158/1538-7445.SABCS19-PD2-07
Published: 15 February 2020
View article titled, Abstract PD2-07: Prediction of CDK inhibitor efficacy in ER+/HER2- breast cancer using machine learning algorithms
Journal Articles

Abstract 3516: A genomics model to predict immune-related adverse events in cancer patients treated with checkpoint inhibitors

Emma C. Scott, Dickran Kazandjian, Luis Santana-Quintero, Tigran Ghazanchyan, Svetlana Petrovskaya, Yong Zhang, Amy Rosenberg, V. Ashutosh Rao, Jennifer L. Marte, Gideon M. Blumenthal, Marc R. Theoret, Richard Pazdur, James L. Gulley, Julia A. Beaver
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 3516.
https://doi.org/10.1158/1538-7445.AM2019-3516
Published: 01 July 2019
View article titled, Abstract 3516: A genomics model to predict immune-related adverse events in cancer patients treated with checkpoint inhibitors
Journal Articles

Abstract 5141: T-cell receptor repertoire analysis by next-generation sequencing peripheral blood mononuclear cells from multiple myeloma or smoldering multiple myeloma patients

Yong Zhang, Svetlana Petrovskaya, Emma C. Scott, Luis Santana-Quintero, Tigran Ghazanchyan, Amy Rosenburg, V. Ashutosh Rao, Gideon M. Blumenthal, Marc Theoret, Richard Pazdur, Julia A. Beaver, Dickran Kazandjian
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 5141.
https://doi.org/10.1158/1538-7445.AM2019-5141
Published: 01 July 2019
View article titled, Abstract 5141: T-cell receptor repertoire analysis by next-generation sequencing peripheral blood mononuclear cells from multiple myeloma or smoldering multiple myeloma patients
Journal Articles

Abstract P1-14-20: Meta-analysis Results from the Collaborative Trials in Neoadjuvant Breast Cancer (CTNeoBC)

Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa, Jo Anne Zujewski, Robert Justice, Sibylle Loibl, Lawrence Wickerham, Jan Bogaerts, Jose Baselga, Charles Perou, Gideon Blumenthal, Jens Blohmer, Eleftherios Mamounas, Jonas Bergh, Vladimir Semiglazov, Tatiana Prowell, Holger Eidtmann, Soonmyung Paik, Martine Piccart, Rajeshwari Sridhara, Peter Fasching, Sandra M Swain, Leen Slaets, Shenghui Tang, Bernd Gerber, Charles Geyer, Richard Pazdur, Nina Ditsch, Priya Rastogi, Wolfgang Eiermann, Gunter von Mincwitz
Journal: Cancer Research
Cancer Res (2012) 72 (24_Supplement): P1-14-20.
https://doi.org/10.1158/0008-5472.SABCS12-P1-14-20
Published: 15 December 2012
View article titled, Abstract P1-14-20: Meta-analysis Results from the Collaborative Trials in Neoadjuvant Breast Cancer (CTNeoBC)
Journal Articles

Management of toxicity: Approval of UGT1A1 genetic test and irinotecan label update

Atiqur Rahman, Shiew-Mei Huang, Mehul U. Mehta, Roshni Ramchandani, Brian P. Booth, Richard Pazdur, Lawrence J. Lesko, Felix Frueh
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 310.
Published: 15 April 2006
View article titled, Management of toxicity: Approval of UGT1A1 genetic test and irinotecan label update
Journal Articles

Acodazole Hydrochloride: Phase I Trial, Pharmacokinetics, and Evaluation of Cardiotoxicity in Dogs

Richard Pazdur, Guy G. Chabot, Colin A. Campbell, Michael H. Lehmann, Robert A. Kloner, Laurence H. Baker
Journal: Cancer Research
Cancer Res (1988) 48 (15): 4423–4426.
Published: 01 August 1988
View article titled, Acodazole Hydrochloride: Phase I Trial, Pharmacokinetics, and Evaluation of Cardiotoxicity in Dogs
Open the PDF for Acodazole Hydrochloride: Phase I Trial, Pharmacokinetics, and Evaluation of Cardiotoxicity in Dogs in another window
Journal Articles

Phase I Trial of Spiromustine (NSC 172112) and Evaluation of Toxicity and Schedule in a Murine Model

Richard Pazdur, Bruce G. Redman, Thomas Corbett, Mary Phillips, Laurence H. Baker
Journal: Cancer Research
Cancer Res (1987) 47 (15): 4213–4217.
Published: 01 August 1987
View article titled, Phase I Trial of Spiromustine (NSC 172112) and Evaluation of Toxicity and Schedule in a Murine Model
Open the PDF for Phase I Trial of Spiromustine (NSC 172112) and Evaluation of Toxicity and Schedule in a Murine Model in another window